Alcohol Use Disorder

ClinicalJuly 12, 2026

Clinical Trial on Cannabidiol for Alcohol Withdrawal Symptoms Initiated

A randomized placebo-controlled trial is underway to assess the efficacy of cannabidiol (CBD) in treating alcohol withdrawal symptoms and cravings in individuals with moderate-to-severe alcohol use disorder.

Companies

Assets

Recent signals(9)

Yale University initiates DMT study for Alcohol Use Disorder

Phase 2 Trial of Psilocybin for Alcohol Use Disorder Initiated by NYU Langone Health

Study on Hepatic Lipid Metabolism in Alcohol Use Disorder Initiated

Pilot Study on Environmental Effects on Alcohol Use Disorder Behavior

Clinical Trial on Cannabidiol for Alcohol Withdrawal Symptoms Initiated

Eli Lilly's Mazdutide Shows Promise in Alcohol Use Disorder Study

NIAAA Launches Study on Addictions Neuroclinical Assessment for Alcohol Use Disorder

Tirzepatide Trial for Metabolic Alcohol-Associated Liver Disease in AUD Patients

Study on Alcohol's Impact on PDE4B Imaging in Healthy Adults

Upcoming catalysts

Indications

Get signals before the market moves